As Pfizer (PFE) Stock Value Declined, Shareholder Spectrum Management Group Trimmed Its Position by $1.43 Million; Encana (ECA) Holder Intact Investment Management Decreased Holding as Stock Price Declined

April 20, 2018 - By Linda Rogers

Pfizer Inc. (NYSE:PFE) Logo

Intact Investment Management Inc decreased its stake in Encana Corp (ECA) by 8.66% based on its latest 2017Q4 regulatory filing with the SEC. Intact Investment Management Inc sold 91,200 shares as the company’s stock declined 11.75% with the market. The institutional investor held 962,300 shares of the oil & gas production company at the end of 2017Q4, valued at $16.13 million, down from 1.05M at the end of the previous reported quarter. Intact Investment Management Inc who had been investing in Encana Corp for a number of months, seems to be less bullish one the $11.89B market cap company. The stock increased 0.39% or $0.05 during the last trading session, reaching $12.73. About 5.86 million shares traded. Encana Corporation (NYSE:ECA) has risen 5.00% since April 20, 2017 and is uptrending. It has underperformed by 6.55% the S&P500.

Spectrum Management Group Inc decreased its stake in Pfizer Inc (PFE) by 90.67% based on its latest 2017Q4 regulatory filing with the SEC. Spectrum Management Group Inc sold 39,808 shares as the company’s stock declined 3.13% with the market. The institutional investor held 4,096 shares of the health care company at the end of 2017Q4, valued at $148,000, down from 43,904 at the end of the previous reported quarter. Spectrum Management Group Inc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $217.51B market cap company. The stock increased 0.10% or $0.035 during the last trading session, reaching $36.565. About 11.85 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since April 20, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Since December 15, 2017, it had 0 insider purchases, and 12 insider sales for $12.99 million activity. SUSMAN SALLY also sold $1.24 million worth of Pfizer Inc. (NYSE:PFE) shares. Shares for $1.84M were sold by LANKLER DOUGLAS M on Tuesday, March 13. Another trade for 9,510 shares valued at $353,677 was made by LUND-JURGENSEN KIRSTEN on Saturday, February 24. $986,292 worth of Pfizer Inc. (NYSE:PFE) was sold by HILL CHARLES H. Shares for $249,750 were sold by MACKENZIE ALEXANDER R on Friday, December 15. CORNWELL W DON had sold 1,758 shares worth $64,679.

Spectrum Management Group Inc, which manages about $448.94M and $289.11M US Long portfolio, upped its stake in Home Depot Inc (NYSE:HD) by 1,655 shares to 15,456 shares, valued at $2.93M in 2017Q4, according to the filing. It also increased its holding in Schwab Strategic Tr (SCHD) by 8,111 shares in the quarter, for a total of 455,981 shares, and has risen its stake in Berkshire Hathaway Inc D (BRKB).

Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer had 78 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets with “Hold” on Monday, June 12. The stock of Pfizer Inc. (NYSE:PFE) has “Outperform” rating given on Tuesday, October 20 by Cowen & Co. The company was maintained on Thursday, July 14 by Jefferies. Morgan Stanley upgraded Pfizer Inc. (NYSE:PFE) on Friday, October 2 to “Overweight” rating. The stock of Pfizer Inc. (NYSE:PFE) has “Overweight” rating given on Wednesday, January 31 by Morgan Stanley. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by UBS on Wednesday, November 1. The firm has “Buy” rating by Deutsche Bank given on Wednesday, October 28. JP Morgan reinitiated Pfizer Inc. (NYSE:PFE) on Thursday, April 7 with “Overweight” rating. The rating was maintained by Cowen & Co on Monday, August 14 with “Buy”. The rating was maintained by Piper Jaffray on Saturday, September 5 with “Overweight”.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1 before the open. They expect $0.73 earnings per share, up 5.80% or $0.04 from last year’s $0.69 per share. PFE’s profit will be $4.34B for 12.52 P/E if the $0.73 EPS becomes a reality. After $0.62 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 17.74% EPS growth.

Investors sentiment increased to 1.06 in Q4 2017. Its up 0.10, from 0.96 in 2017Q3. It increased, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Moreover, Van Hulzen Asset Management Ltd Limited Liability Company has 1% invested in Pfizer Inc. (NYSE:PFE). Wall Street Access Asset Mngmt Limited Liability stated it has 1.58% in Pfizer Inc. (NYSE:PFE). Muhlenkamp & Co holds 0.29% or 27,494 shares. Delta Asset Mgmt Limited Company Tn owns 44,254 shares. Cullinan Assoc has invested 0.82% in Pfizer Inc. (NYSE:PFE). Auxier Asset has 78,618 shares. Doheny Asset Mgmt Ca accumulated 59,804 shares. Cornercap Counsel Inc stated it has 104,437 shares or 0.52% of all its holdings. Next Group holds 29,452 shares or 0.46% of its portfolio. 6,307 are owned by Eubel Brady Suttman Asset Mngmt. Daniel Devine reported 59,662 shares. Natl Pension Serv has 4.64M shares. Sumitomo Life Insurance Co has 192,491 shares for 0.87% of their portfolio. D E Shaw And holds 3.17M shares. 18,583 were accumulated by Capital Mgmt Assoc.

Among 28 analysts covering Encana Corporation (NYSE:ECA), 26 have Buy rating, 1 Sell and 1 Hold. Therefore 93% are positive. Encana Corporation had 129 analyst reports since July 21, 2015 according to SRatingsIntel. The company was upgraded on Tuesday, January 24 by Macquarie Research. The firm has “Buy” rating by Canaccord Genuity given on Tuesday, June 20. GMP Securities maintained Encana Corporation (NYSE:ECA) on Friday, September 29 with “Buy” rating. The stock of Encana Corporation (NYSE:ECA) has “Buy” rating given on Tuesday, January 16 by RBC Capital Markets. Deutsche Bank maintained Encana Corporation (NYSE:ECA) on Tuesday, June 14 with “Buy” rating. As per Tuesday, September 8, the company rating was maintained by Barclays Capital. The rating was maintained by GMP Securities with “Buy” on Thursday, November 9. On Thursday, July 20 the stock rating was maintained by Desjardins Securities with “Hold”. The company was downgraded on Thursday, June 23 by Macquarie Research. Altacorp maintained the shares of ECA in report on Wednesday, September 27 with “Buy” rating.

Analysts await Encana Corporation (NYSE:ECA) to report earnings on May, 1. They expect $0.17 earnings per share, up 54.55% or $0.06 from last year’s $0.11 per share. ECA’s profit will be $158.78M for 18.72 P/E if the $0.17 EPS becomes a reality. After $0.12 actual earnings per share reported by Encana Corporation for the previous quarter, Wall Street now forecasts 41.67% EPS growth.

Intact Investment Management Inc, which manages about $2.49 billion US Long portfolio, upped its stake in Telus Corp (NYSE:TU) by 605,200 shares to 1.82 million shares, valued at $86.54M in 2017Q4, according to the filing. It also increased its holding in Gildan Activewear Inc (NYSE:GIL) by 27,100 shares in the quarter, for a total of 88,600 shares, and has risen its stake in Cae Inc (NYSE:CAE).

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts